Unbiased immunome characterisation correlates with COVID-19 mRNA vaccine failure in immunocompromised adults.

Autor: H-Vázquez J; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Cal-Sabater P; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Arribas-Rodríguez E; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Fiz-López A; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Perez-Segurado C; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Martín-Muñoz Á; Flow Cytometry Facility, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., De Prado Á; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Perez Mazzali M; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., de Castro CG; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Del Hierro AG; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., de la Fuente Graciani I; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Pérez González S; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Gutiérrez S; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Tellería P; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Novoa C; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Rojo Rello S; Microbiology and Inmunology Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Garcia-Blesa A; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Sedano R; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Martínez García AM; Microbiology and Inmunology Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Garcinuño Pérez S; Microbiology and Inmunology Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Domínguez-Gil M; Microbiology Department, Hospital Universitario Río Hortega, Valladolid, Spain., Hernán García C; Servicio de Medicina Preventiva, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Guerra MM; Servicio de Medicina Preventiva, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Muñoz-Sánchez E; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Barragan-Pérez C; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Diez Morales S; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Casazza Donnarumma O; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Ramos Pollo D; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Santamarta Solla N; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Álvarez Manzanares PM; Unidad de Cuidados Paliativos del Hospital Universitario Río Hortega, Valladolid, Spain., Bravo S; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., García Alonso C; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Avendaño Fernández LA; Servicio de Prevención de Riesgos Laborales, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Gay Alonso J; Residencia y Centro de Día ORPEA Valladolid, Valladolid, Spain., Garrote JA; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Arranz E; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Eiros JM; Microbiology Department, Hospital Universitario Río Hortega, Valladolid, Spain., Rescalvo Santiago F; Servicio de Prevención de Riesgos Laborales, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Quevedo Villegas C; Servicio de Prevención de Riesgos Laborales, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Tamayo E; Unidad Investigación, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.; Centro de Investigaciones Biomédicas en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Orduña A; Microbiology and Inmunology Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Dueñas C; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Peñarrubia MJ; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Cuesta-Sancho S; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain., Montoya M; Viral Immunology, Therapies and Vaccines Lab, Centro de Investigaciones Biológicas Margarita Salas (CIB), Madrid, Spain., Bernardo D; Mucosal Immunology Lab, Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM, University of Valladolid-CSIC), Valladolid, Spain.; Centro de Investigaciones Biomédicas en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Nov 14; Vol. 15, pp. 1405217. Date of Electronic Publication: 2024 Nov 14 (Print Publication: 2024).

RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022.

Autor: Haeberer M; Pfizer SLU, Av Europa 20B, 28108, Madrid, Spain. mariana.haeberer@pfizer.com.; Pfizer Inc, Collegeville, USA. mariana.haeberer@pfizer.com., Mengel M; Independent Consultant, Valencia, Spain., Fan R; Pfizer Inc, Collegeville, USA., Toquero-Asensio M; National Influenza Centre, Valladolid, Spain.; Instituto de Estudios de Ciencias de la Salud de Castilla y León, ICSCYL, Soria, Spain., Martin-Toribio A; National Influenza Centre, Valladolid, Spain., Liu Q; Pfizer Inc, Collegeville, USA., He Y; Pfizer Inc, Collegeville, USA., Uppal S; Pfizer Inc, Collegeville, USA., Rojo-Rello S; National Influenza Centre, Valladolid, Spain.; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Domínguez-Gil M; National Influenza Centre, Valladolid, Spain.; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Hernán-García C; National Influenza Centre, Valladolid, Spain.; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Fernández-Espinilla V; National Influenza Centre, Valladolid, Spain.; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Liang C; Pfizer Inc, Collegeville, USA., Begier E; Pfizer Inc, Collegeville, USA., Castrodeza Sanz J; National Influenza Centre, Valladolid, Spain.; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Eiros JM; National Influenza Centre, Valladolid, Spain.; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Sanz-Muñoz I; Instituto de Estudios de Ciencias de la Salud de Castilla y León, ICSCYL, Soria, Spain.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Sep; Vol. 13 (9), pp. 1983-1999. Date of Electronic Publication: 2024 Jul 21.

Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19.

Autor: de la Fuente A; Group for Biomedical Research in Sepsis (BioSepsis). Instituto de Investigación Biomédica de Salamanca, (IBSAL), Gerencia Regional de Salud de Castilla y León, Paseo de San Vicente, Salamanca, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB22/06/00035), Instituto de Salud Carlos III, Madrid, Spain., Postigo T; Group for Biomedical Research in Sepsis (BioSepsis). Instituto de Investigación Biomédica de Salamanca, (IBSAL), Gerencia Regional de Salud de Castilla y León, Paseo de San Vicente, Salamanca, Spain., Sanus Ferri F; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB07/06/2008), Instituto de Salud Carlos III, Madrid, Spain., Domínguez-Gil M; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB22/06/00035), Instituto de Salud Carlos III, Madrid, Spain; Microbiology Service, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain., Álvarez-Manzanares J; Emergency Department, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain., Eiros JM; Microbiology Service, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain., Carbajosa Rodríguez V; Emergency Department, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain., Sanchez Ramon S; Emergency Department, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain., Ortega A; Group for Biomedical Research in Sepsis (BioSepsis). Instituto de Investigación Biomédica de Salamanca, (IBSAL), Gerencia Regional de Salud de Castilla y León, Paseo de San Vicente, Salamanca, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB22/06/00035), Instituto de Salud Carlos III, Madrid, Spain., Fadrique Millán LN; Emergency Department, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain., Vaquero-Roncero LM; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB22/06/00035), Instituto de Salud Carlos III, Madrid, Spain; Anaesthesiology and Reanimation Service, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain., Esteban-Velasco C; Department of General and Gastrointestinal Surgery, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL) and Universidad de Salamanca, Salamanca, Spain., Navarro-Matías E; Primary Care Research Unit of Salamanca (APISAL), Salamanca Primary Care Management, Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Castilla and León Health Service-SACYL, Gerencia Regional de Salud, Valladolid, Spain., Barbé F; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB07/06/2008), Instituto de Salud Carlos III, Madrid, Spain; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRB Lleida, Lleida, Spain., Bermejo-Martin JF; Group for Biomedical Research in Sepsis (BioSepsis). Instituto de Investigación Biomédica de Salamanca, (IBSAL), Gerencia Regional de Salud de Castilla y León, Paseo de San Vicente, Salamanca, Spain; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB22/06/00035), Instituto de Salud Carlos III, Madrid, Spain; School of Medicine, Universidad de Salamanca, Salamanca, Spain. Electronic address: jfbermejo@saludcastillayleon.es., Lopez-Izquierdo R; Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES, CB22/06/00035), Instituto de Salud Carlos III, Madrid, Spain; Emergency Department, Hospital Universitario Rio Hortega, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Mar; Vol. 140, pp. 132-135. Date of Electronic Publication: 2024 Feb 02.

Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain

Autor: Cabrerizo, M., Tarragó, D., Muñoz-Almagro, C., del Amo, E., Domínguez-Gil, M., Eiros, J. M, López-Miragaya, I., Pérez, C., Reina, J., Otero, A., González, I., Echevarría, J.E., Trallero, G.

Publikováno v: In Clinical Microbiology and Infection March 2014 20(3):O150-O156

Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults.

Autor: Sanz-Muñoz I, Sánchez-dePrada L, Sánchez-Martínez J, Rojo-Rello S, Domínguez-Gil M, Hernán-García C, Fernández-Espinilla V, de Lejarazu-Leonardo RO, Castrodeza-Sanz J, Eiros JM

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2023 Mar; Vol. 29 (3), pp. 656-658. Date of Electronic Publication: 2023 Feb 02.